Cargando…

β-blockers after myocardial infarction and 1-year clinical outcome – a retrospective study

BACKGROUND: Long term β-blocker therapy after myocardial infarction (MI) reduces mortality and recurrent MI but evidence for this treatment predates contemporary acute coronary care. β-blocker treatment is a key quality of care indicator in the Swedish national quality register for acute coronary ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagsund, Tora, Olsson, Sven-Erik, Smith, J. Gustav, Madsen Hardig, Bjarne, Wagner, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146968/ https://www.ncbi.nlm.nih.gov/pubmed/32272880 http://dx.doi.org/10.1186/s12872-020-01441-0

Ejemplares similares

Mechanical chest compressions for cardiac arrest in the cath-lab: when is it enough and who should go to extracorporeal cardio pulmonary resuscitation?
por: Madsen Hardig, Bjarne, et al.
Publicado: (2019)

Arrhythmia-provoking factors and symptoms at the onset of paroxysmal atrial fibrillation: A study based on interviews with 100 patients seeking hospital assistance
por: Hansson, Anders, et al.
Publicado: (2004)

Effect of β‐Blockers Beyond 3 Years After Acute Myocardial Infarction
por: Park, Jin Joo, et al.
Publicado: (2018)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
por: Andell, Pontus, et al.
Publicado: (2015)

Can pulsed ultrasound increase tissue damage during ischemia? A study of the effects of ultrasound on infarcted and non-infarcted myocardium in anesthetized pigs
por: Olivecrona, Göran K, et al.
Publicado: (2005)

Due caution using early β-blockers for acute myocardial infarction
por: McKee, Scott, et al.
Publicado: (2007)

Association between β-blocker dose and quality of life after myocardial infarction: a real-world Swedish register-linked study
por: Humphries, Sophia, et al.
Publicado: (2022)

Repeated epinephrine doses during prolonged cardiopulmonary resuscitation have limited effects on myocardial blood flow: a randomized porcine study
por: Wagner, Henrik, et al.
Publicado: (2014)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Effect of β-Blockers on the Risk of Atrial Fibrillation in Patients with Acute Myocardial Infarction
por: Pesaro, Antonio Eduardo, et al.
Publicado: (2010)

Evaluation of coronary blood flow velocity during cardiac arrest with circulation maintained through mechanical chest compressions in a porcine model
por: Wagner, Henrik, et al.
Publicado: (2011)

Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone
por: Härdig, Bjarne Madsen, et al.
Publicado: (2008)

Mechanical chest compressions in the coronary catheterization laboratory to facilitate coronary intervention and survival in patients requiring prolonged resuscitation efforts
por: Wagner, Henrik, et al.
Publicado: (2016)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

β‐Blocker Therapy After Myocardial Infarction: A Little Goes a Long Way
por: Abbott, J. Dawn, et al.
Publicado: (2023)

Sustained beneficial effect of β-blockers on clinical outcomes after discontinuation in patients with ST elevation myocardial infarction
por: Park, Jin-Sun, et al.
Publicado: (2023)

Selection of β‐Blocker in Patients With Cirrhosis and Acute Myocardial Infarction: A 13‐Year Nationwide Population‐Based Study in Asia
por: Wu, Victor Chien‐Chia, et al.
Publicado: (2018)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis
por: Dahl Aarvik, Magnus, et al.
Publicado: (2019)

One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction
por: Goldberger, Jeffrey J., et al.
Publicado: (2021)

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
por: Puymirat, Etienne, et al.
Publicado: (2016)

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study
Publicado: (2016)

Long-term efficacy of vasodilating β-blocker in patients with acute myocardial infarction: nationwide multicenter prospective registry
por: Chung, Jaehoon, et al.
Publicado: (2021)

Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention
por: Fukase, Tatsuya, et al.
Publicado: (2021)

Effects of αβ-Blocker Versus β1-Blocker Treatment on Heart Rate Response During Incremental Cardiopulmonary Exercise in Japanese Male Patients with Subacute Myocardial Infarction
por: Nemoto, Shinji, et al.
Publicado: (2019)

Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021)

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
por: Joo, Seung-Jae
Publicado: (2023)

Randomized evaluation of routine beta-blocker therapy after myocardial infarction quality of life (RQoL): design and rationale of a multicentre, prospective, randomized, open, blinded endpoint study
por: Humphries, Sophia, et al.
Publicado: (2023)

Benefit of Vasodilating β‐Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention: Nationwide Multicenter Cohort Study
por: Chung, Jaehoon, et al.
Publicado: (2017)

Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019)

Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review
por: Lanham, David, et al.
Publicado: (2019)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
por: Amino, Mari, et al.
Publicado: (2021)

Assessment of increasing intravenous adenosine dose in fractional flow reserve
por: Sparv, David, et al.
Publicado: (2017)

Metrics of mechanical chest compression device use in out‐of‐hospital cardiac arrest
por: Levy, Michael, et al.
Publicado: (2020)

Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records
por: Quint, J K, et al.
Publicado: (2013)

β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study
por: Su, Tse-Hsuan, et al.
Publicado: (2019)

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction
por: Chen, Chih-Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tou4inhqph0uspf9jorofiptha